Swedish Orphan Biovitrum AB (publ) (LON:0MTD)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Immunology	7.81B	8.33B	7.64B	6.68B	5.78B
Immunology Growth	-6.28%	9.13%	14.31%	15.55%	6.74%
Haematology	19.12B	16.43B	13.37B	10.83B	8.54B
Haematology Growth	16.36%	22.88%	23.44%	26.89%	-1.43%
Specialty Care	1.31B	1.27B	1.12B	1.28B	1.21B
Specialty Care Growth	3.55%	13.23%	-12.58%	5.52%	2.28%
Total	28.24B	26.03B	22.12B	18.79B	15.53B
Total Growth	8.49%	17.65%	17.74%	21.00%	1.76%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
International	2.93B	2.65B	2.44B	1.15B
International Growth	10.25%	8.82%	112.55%	33.84%
Other	4.90B	2.72B	1.43B	1.25B
Other Growth	80.24%	90.47%	14.07%	-3.84%
Europe (Excluding Sweden)	9.04B	7.85B	6.82B	-
Europe (Excluding Sweden) Growth	15.11%	15.17%	-	-
North America (Excluding United States)	142.00M	93.00M	77.00M	66.00M
North America (Excluding United States) Growth	52.69%	20.78%	16.67%	37.50%
Sweden	653.00M	660.00M	667.00M	678.00M
Sweden Growth	-1.06%	-1.05%	-1.62%	-5.83%
United States	8.37B	8.15B	7.36B	6.05B
United States Growth	2.74%	10.65%	21.64%	11.39%
France	-	-	-	1.81B
France Growth	-	-	-	-7.91%
Germany	-	-	-	1.23B
Germany Growth	-	-	-	-14.67%
Rest of Europe	-	-	-	3.30B
Rest of Europe Growth	-	-	-	-5.72%
Total	26.03B	22.12B	18.79B	15.53B
Total Growth	17.65%	17.74%	21.00%	1.76%

Source: S&P Global Market Intelligence.